We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 dividend stocks that could pay you for the rest of your life

G A Chester reveals a FTSE 100 (INDEXFTSE:UKX) giant and two other dividend stocks he’d be happy to buy and hold for decades.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

There’s a lot to be said for investing in dividend stocks. They can provide an income stream or a high total return from reinvesting the dividends. Furthermore, there’s good reason to be snapping them up right now. Here are three I’d be happy to buy and hold for decades.

Global giant

Have you got a jar of Marmite, Bovril or Colman’s mustard in your food cupboard? PG Tips in your tea caddy? Hellmann’s mayonnaise in your fridge? Ben & Jerry’s or Magnum ice cream in your freezer? Persil washing powder or a Cif cleaner under your kitchen sink? Domestos, Dove soap or TRESemmé shampoo in your bathroom?

Should you buy Fuller, Smith & Turner P.l.c. shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

These are just a few of over 400 brands owned by FTSE 100 Anglo-Dutch consumer goods giant Unilever (LSE: ULVR). It owns some of the best known and biggest selling household brands in the world, including 12 that have sales of more than €1bn a year. On any given day, 2.5bn people around the world use Unilever products.

The group is a cash-generating machine and is of such a size it can easily buy other blue-ribbon brands, if they become available. For example, earlier this month, it announced the €3.3bn acquisition of Horlicks and other health food drinks in India, Bangladesh and 20 other predominantly Asian markets from GlaxoSmithKline.

I view a rating of a little over 20 times calendar 2018 forecast earnings as excellent value for this world-class business. And I expect years of continued dividend growth from an initial yield of 3.2%.

Emerging markets story

Mid-cap PZ Cussons (LSE: PZC) can’t match Unilever for global spread, nor does it own any brands that generate sales of more than €1bn a year. Total sales for its current financial year (ending May 2019) are forecast to be around £740m. However, it does operate in a fair number of countries, including a notable presence in emerging markets. And it owns some very decent brands, including Imperial Leather, Carex and Original Source.

Growth has been checked in recent years by a challenging economic backdrop in Nigeria (one of its most significant markets). However, I believe the story of increasing population and affluence in emerging markets remains intact, and bodes well for the company’s long-term prospects.

A rating of 16 times forecast earnings for its current financial year is cheap by historical standards and a prospective dividend yield of 3.9% is well above its historical average. With earnings and dividend growth forecast to resume in the company’s next financial year, I see great value here for long-term investors.

Venerable UK business

Brewer and pubs group Fuller, Smith & Turner (LSE: FSTA) is a UK-focused business. Its estate, which includes many landmark houses, is concentrated in London and the south east. Its positioning in and around one of the world’s most vibrant capital cities has enabled the business to thrive since its foundation in the mid-19th century.

Remarkably, descendants of the founders remain significant shareholders. And there are Fullers and Turners on the board of directors, ensuring the business continues to be conservatively stewarded with a long-term perspective. The company has a terrific record of annual dividend growth, putting many FTSE 100 firms to shame.

Trading on 14 times forecast earnings for its current financial year (ending March 2019), and with a prospective 2.3% yield, I see this is another great-value dividend stock that could pay you for the rest of your life.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK owns shares of PZ Cussons. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

At 8.1%, are investors missing the bigger story behind Legal & General shares?

Andrew Mackie explores Legal & General shares and asks whether investors are still viewing it too narrowly as a yield…

Read more »

Young black female footballer training on stadium pitch
Investing Articles

How has this FTSE 250 share surged ANOTHER 7% today?

Applied Nutrition shares have soared on Monday after another brilliant trading update. So what's the FTSE 250 company's secret?

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The stock market game you’re actually playing (and why you might be losing)

Our writer recounts a painful experience of making a rash stock market decision based on emotions, not logic – and…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Why is EasyJet stock suddenly a takeover target for US investors?

Andrew Mackie looks at easyjet shares jumping on US takeover talk — but is this a genuine re-rating or just…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

Have investors got BT shares all wrong?

BT shares spiked during the 1990s telecom boom, then struggled for two decades. Harvey Jones says it's the future that…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

Looking for buying opportunities in June? Here’s 1 to consider from my Stocks and Shares ISA

The conflict in Iran is making one of the investments in Stephen Wright’s Stocks and Shares ISA volatile. But could…

Read more »

Row of blue European Union flags in Brussels.
Investing Articles

After crashing 13.7% today, is Wise now a stock market bargain at 805p?

Wise was one of the biggest fallers on the UK stock market today. What on earth is going on with…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

At 8% is this eye-popping FTSE 100 dividend yield simply too good to be true?

The dividend yield is to die for, but the share price is lacking in life. Harvey Jones examines whether this…

Read more »